The Ghana AIDS Commission (GAC) has revealed plans to introduce an HIV preventive drug in 2026 as part of its strategy to reduce the spread of the virus, which saw over 15,000 new infections recorded last year.
Speaking on Tuesday, September 30, the Commission’s Director-General, Dr. Prosper Akanbong, said the initiative is designed not only to strengthen prevention measures but also to enhance Ghana’s capacity for local pharmaceutical production.
“As a country, we have already put the vaccine as a main component of our HIV prevention programme. Initially, we will secure it from outside, but with the pharmacy organisations that you see here, they have positioned themselves to be able to produce the vaccines locally,” Dr. Akanbong explained.
He noted that talks have already been held with pharmaceutical firms, with technical and logistical support from GIZ, to ensure a sustainable rollout of the preventive drug.
“Together with GIZ, we are on track, and in the latter part of 2026 or the early part of 2027, we should be able to produce vaccines for Ghana,” he added.
The move is expected to mark a significant step forward in Ghana’s fight against HIV, combining international collaboration with local production to ensure long-term availability and accessibility.
Leave a Reply